BamSEC and AlphaSense Join Forces
Learn More

ImageneBio Inc. – Material Contracts

NASDAQ: IMA    
Share price (9/29/26): $4.58    
Market cap (9/29/26): $52.0 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 3 pages Appendix a Participation Agreement
12/34/56
EX-10.2
from 8-K 14 pages Imagenebio, Inc. Severance and Change in Control Plan
12/34/56
EX-10.1
from 8-K 7 pages July 12, 2026 Yanina Grant Re: Offer of Employment Dear Yanina: We Are Pleased to Offer You At-Will Employment in the Position of Chief Financial Officer of Imagenebio, Inc. (The “Company”) on the Terms and Conditions Set Forth in This Letter Agreement (The “Agreement”)
12/34/56
EX-10.1
from 8-K 34 pages Imagenebio, Inc. Amended and Restated 2025 Equity Incentive Plan Adopted by the Board of Directors: December 12, 2024 Approved by the Stockholders: July 15, 2025 Amended and Restated by the Board of Directors: April 27, 2026 Approved by the Stockholders: June 16, 2026
12/34/56
EX-10.1
from 8-K 52 pages Securities Purchase Agreement
12/34/56
EX-10.17
from 10-K 3 pages Imagenebio, Inc. Non-Employee Director Compensation Policy Adopted December 18, 2025
12/34/56
EX-10.10
from S-1 8 pages Indemnification Agreement
12/34/56
EX-10.5
from S-1 14 pages Imagenebio, Inc. 2025 Employee Stock Purchase Plan Adopted by the Board of Directors: December 12, 2024 Approved by the Stockholders: July 15, 2025 Effective Date: July 26, 2025
12/34/56
EX-10.2
from S-1 34 pages Imagenebio, Inc. 2025 Equity Incentive Plan Adopted by the Board of Directors: December 12, 2024 Approved by the Stockholders: July 15, 2025
12/34/56
EX-10.23
from 8-K 14 pages Imagenebio, Inc. 2025 Employee Stock Purchase Plan Adopted by the Board of Directors: December 12, 2024 Approved by the Stockholders: July 15, 2025 Effective Date: July 26, 2025
12/34/56
EX-10.22
from 8-K 5 pages Imagenebio, Inc. Rsu Award Grant Notice
12/34/56
EX-10.21
from 8-K 8 pages Imagenebio, Inc. Stock Option Grant Notice
12/34/56
EX-10.20
from 8-K 34 pages Imagenebio, Inc. 2025 Equity Incentive Plan Adopted by the Board of Directors: December 12, 2024 Approved by the Stockholders: July 15, 2025
12/34/56
EX-10.18
from 8-K 5 pages July 23, 2025 Jonathan Jian Wang, PH.D., Mba via Email to [***] Re: Separation Agreement Dear Dr. Wang: This Letter Sets Forth the Substance of the Separation Agreement (The “Agreement”) That Inmagene Biopharmaceuticals (The “Company”) Is Offering to You to Aid in Your Employment Transition
12/34/56
EX-10.14
from 8-K 18 pages Employment Agreement
12/34/56
EX-10.10
from 8-K 16 pages Employment Agreement
12/34/56
EX-10.9
from 8-K 12 pages July 23, 2025 Kristin Yarema, PH.D. [***] Re: Offer of Employment Dear Dr. Yarema
12/34/56
EX-10.8
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 27 pages Transition Services Agreement Dated as of July 25, 2025 by and Between Miragene Inc and Inmagene Biopharmaceuticals
12/34/56
EX-10.3
from 8-K 21 pages Company Contingent Value Rights Agreement
12/34/56